Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Noninterventional Study With Certolizumab Pegol in Comparison With Any Other Subcutaneous TNF Inhibitor in Two Parallel Groups in Biologic Naive Patients With Rheumatoid Arthritis

NCT01764321 is registered in ClinicalTrials.gov with UCB Pharma SA as lead sponsor.

NCT NCT01764321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Noninterventional Study With Certolizumab Pegol in Comparison With Any Other Subcutaneous TNF Inhibitor in Two Parallel Groups in Biologic Naive Patients With Rheumatoid Arthritis
Lead sponsor
UCB Pharma SA
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
June 16, 2020
Enrollment
1,723 (actual)
Sites
122

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis